Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | S100B | P04271 | 1/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGAV | P06756 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | GALR3 | O60755 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.38 |
| ▸ | HTR3B | O95264 | 1/20 | 0.38 |
| ▸ | HTR3A | P46098 | 1/20 | 0.38 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.38 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.38 |
| ▸ | PNMT | P11086 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29862583 | 1.00 | CYP3A4 (0.54) | CYP3A4S100BITGB3ITGAVTDP1 | |
| Ammonia Solution, Strong SCHEMBL28180433 | 0.98 | CYP3A4 (0.52) | CYP3A4S100BITGB3ITGAVTDP1 | |
| SCHEMBL7529492 | 0.94 | CYP3A4 (0.48) | CYP3A4S100BITGB3ITGAVTDP1 | |
| SCHEMBL11554107 | 0.92 | CYP3A4 (0.52) | CYP3A4S100BITGB3ITGAVTDP1 | |
| SCHEMBL58545 | 0.89 | CYP3A4 (0.60) | CYP3A4S100BITGB3ITGAVTDP1 | |
| Toluene SCHEMBL28174798 | 0.88 | CYP3A4 (0.52) | CYP3A4S100BITGB3ITGAVTDP1 | |
| SCHEMBL8943163 | 0.88 | TDP1 (0.44) | CYP3A4S100BITGB3ITGAVTDP1 | |
| SCHEMBL8417246 | 0.82 | S100B (0.46) | CYP3A4S100BITGB3ITGAVGALR3 | |
| SCHEMBL29537333 | 0.82 | CYP3A4 (0.52) | CYP3A4TDP1GABRA1GABRB2MAPK1 | |
| SCHEMBL93270 | 0.82 | CYP3A4 (0.52) | CYP3A4TDP1GABRA1GABRB2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 794 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509547-B2 | Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component | BASF SE (DE) | 2025-12-30 | — | — | US | claimed |
| WO-2024099083-A1 | PRODUCTION PROCESS FOR CRUDE ISOCYANATE HAVING LOW SINGLE-BENZENE-RING IMPURITY CONTENT | 万华化学（宁波）有限公司 | 2024-05-16 | — | — | WO | claimed |
| CN-118026893-A | Production process of crude isocyanate with low content of mono-benzene ring impurities | 万华化学（宁波）有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-20230348657-A1 | SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT | BASF SE (DE) | 2023-11-02 | — | — | US | claimed |
| CN-111471171-B | Arylsulfonic acid intermediate, preparation method thereof and application of aryl sulfonic acid intermediate in synthesizing low-temperature-sensitivity additive for concrete | 江苏苏博特新材料股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| EP-4185626-A1 | SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT | BASF SE (DE) | 2023-05-31 | — | — | EP | claimed |
| CN-112996835-B | Method for producing thermoplastic polyoxazolidone polymers | 科思创知识产权两合公司 | 2022-12-13 | — | — | CN | claimed |
| US-11427671-B2 | Method for the production of thermoplastic polyoxazolidinone polymers | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2022-08-30 | — | — | US | claimed |
| EP-3873961-B1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-08-17 | — | — | EP | claimed |
| US-11370874-B2 | Method for the production of thermoplastic polyoxazolidone polymers | COVESTRO DEUTSCHLAND AG (DE) | 2022-06-28 | — | — | US | claimed |
| WO-2016128380-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-08-18 | — | — | WO | claimed |
| CN-104529824-B | A kind of process for purification of 3,5-dichlorophenyl isocyanate | 青岛科技大学 | 2016-07-06 | — | — | CN | claimed |
| CN-104529824-A | Method for refining 3,5-dichlorophenyl isocyanate | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2015-04-22 | — | — | CN | claimed |
| CN-103304446-B | Derivatization method of optically active phenylacetylene compound | UNIV HARBIN ENG | 2015-02-25 | — | — | CN | claimed |
| CN-104356028-A | Method for continuously preparing 3,4-dichlorophenyl isocyanate | HUNAN HAILI CHANGDE PESTICIDE & CHEMICAL INDUSTRY CO LTD | 2015-02-18 | — | — | CN | claimed |
| CN-101766995-A | Bonding polysaccharide chiral separation liquid chromatogram stationary phase material and synthetic method thereof | ZHONGSHAN HITUR BIO TECHNOLOGI | 2010-07-07 | — | — | CN | claimed |
| US-20090216006-A1 | COVALENTLY BOUND POLYSACCHARIDE-BASED CHIRAL STATIONARY PHASES AND METHOD FOR THEIR PREPARATION | XU HUI | 2009-08-27 | — | — | US | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| WO-2002022354-A1 | RESIN COMPATIBILIZED STARCH-OIL SIZING | PPG INDUSTRIES OHIO, INC. (US) | 2002-03-21 | — | — | WO | claimed |
| US-4918148-A | IMPROVED FLOWABILITY, MOLD RELEASE AND-OR NOTCHED IMPACT STRENGTH | BAYER AKTIENGESELLSCHAFT (DE) | 1990-04-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509547-B2 | Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component | BMP1, BMP4, PBRM1 | CYP3A4 1801/4885S100B 3073/4885ITGB3 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.